Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02308085 |
Recruitment Status :
Active, not recruiting
First Posted : December 4, 2014
Last Update Posted : April 23, 2024
|
Sponsor:
ETOP IBCSG Partners Foundation
Collaborators:
Alliance for Clinical Trials in Oncology
Canadian Cancer Trials Group
Breast International Group
Information provided by (Responsible Party):
ETOP IBCSG Partners Foundation
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | December 2025 |
Estimated Study Completion Date : | December 2028 |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):